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www.sciencedirect.comEditorialThe research process for new drug is complicated, time-consum-
ing, and costly. Thousands of chemical compounds must be made
and tested in an effort to ﬁnd one that can achieve a desirable
result. It may take approximately ten years to study and test a
new drug before it can be approved for the general public.
However, in today's pharmaceutical industry drug delivery has
become keys in drug product development. New innovative
pharmaceutical technologies allow for increased performance of
new and existing pharmaceutical compounds. Patients will beneﬁt
from the enhanced efﬁcacy of pharmaceutical products and from
reduction of side-effects. The research on drug delivery and
pharmaceutical technologies can highly facilitate drug product
development by improving drug solubility, bioavailability, stabi-
lity, and compliance.inese Pharmaceutical Association and Institute of Materia
16/j.apsb.2014.01.003
esponsibility of Institute of Materia Medica, Chinese Ac
ess under CC BY-NC-ND license.In this special issue on drug delivery and pharmaceutical
technology, several review articles presented hot topics of drug
development such as solid dispersion for poorly water-soluble
drugs, kidney-targeted drug delivery, and applications of formula-
tion and drug delivery to improve the drugability. The scientists
from the United States, Canada, England, and China contributed
valuable research works on novel drug delivery and pharmaceu-
tical technologies. We hope that this special issue could provide
beneﬁts to readers in the ﬁeld of pharmaceutical research and
development.Cover storyCrosslinked hydrogels are a promising class of water-insoluble
carriers for amorphous solid dispersions to enhance the delivery of
poorly soluble drugs. During dissolution from hydrogel-based
solid molecular dispersions (e.g., as hydrogel beads shown in the
cover image) under nonsink conditions as normally encountered in
the GI track, the entrapped amorphous drug is ﬁrst converted into
highly supersaturated solution by the imbibed water and then
diffuses out of the hydrogel network. The resulting buildup of drug
supersaturation in the external dissolution medium reduces the
diffusional driving force for the drug to be further released from
the hydrogel matrix (i.e., a feedback-controlled diffusion mechan-
ism). This prevents a surge of supersaturation in the dissolution
medium thus avoiding the critical supersaturation window and theundesirable nucleation and crystallization events leading to a sharp
decrease in drug concentration normally associated with conven-
tional solid dispersions in soluble polymers. Any subsequent
reduction in external drug concentration due to nucleation and
crystallization events will promote additional drug release from the
hydrogel matrix to maintain supersaturation. Such a coupled
feedback-controlled balancing scheme will continue until no drug
can be further released from the hydrogel matrix thus achieving a
more sustained level of supersaturation than that based on water-
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